Ozempic for Heart Disease — The New Research

Ozempic for Heart Disease — Uncover the breakthrough science with Julia Cartwright

Join host Julia Cartwright as she explores how Ozempic, widely known for weight loss, is emerging as a groundbreaking treatment for heart disease. Through compelling insights into major clinical trials, Julia reveals who benefits most and tackles the critical access issues surrounding this potential cardiac game-changer. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Ozempic for Heart Disease — The New Research - Who Gets the Drug and Who Gets Left Behind

Julia Cartwright examines who can actually access semaglutide's life-saving heart benefits after FDA approval. She explores the SELECT trial's 20% cardiac event reduction, the 6.6 million eligible Americans, insurance barriers, cost challenges, and the stark gap between proven science and real-world accessibility for cardiovascular disease patients. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Ozempic for Heart Disease — The New Research - The Mystery Inside the Mechanism

Julia Cartwright explores how Ozempic delivers a 20% reduction in major cardiovascular events through mechanisms beyond weight loss—including dramatic inflammation reduction, improved vascular function, and lipid profile enhancement. The science reveals this diabetes medication may be one of the most important heart disease treatments of our generation. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Ozempic for Heart Disease — The New Research - The Trial That Changed Everything

Join host Julia Cartwright as she explores the groundbreaking SELECT trial — a massive study showing semaglutide reduced heart attacks and strokes by 20% in patients with existing cardiovascular disease. This landmark research earned the first-ever FDA cardiovascular approval for a weight-loss drug, reshaping how we treat heart disease and offering new hope for millions already on standard cardiac medications. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.